Company Participants
Mark Wilterding – Vice President of Investor Relations
Bernard Zovighian – CEO & Director
Daniel Lippis – Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)
Daveen Chopra – Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
YJ Oh – Senior Vice President of Surgical & GM
Todd Brinton – Corporate VP of Advanced Technology & Chief Scientific Officer
Diane Gomez-Thinnes
Scott Ullem – Corporate VP & CFO
Conference Call Participants
David Roman – Goldman Sachs Group, Inc., Research Division
Travis Steed – BofA Securities, Research Division
Shagun Singh Chadha – RBC Capital Markets, Research Division
Robert Marcus – JPMorgan Chase & Co, Research Division
Joanne Wuensch – Citigroup Inc., Research Division
Christopher Pasquale – Nephron Research LLC
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Matthew Miksic – Barclays Bank PLC, Research Division
Danielle Antalffy – UBS Investment Bank, Research Division
Marie Thibault – BTIG, LLC, Research Division
Frederick Wise – Stifel, Nicolaus & Company, Incorporated, Research Division
Matthew Taylor – Jefferies LLC, Research Division
Jayson Bedford – Raymond James & Associates, Inc., Research Division
Richard Newitter – Truist Securities, Inc., Research Division
Pito Chickering – Deutsche Bank AG, Research Division
Joshua Jennings – TD Cowen, Research Division
Edward Ridley-Day – Rothschild & Co Redburn, Research Division
Presentation
Mark Wilterding
Vice President of Investor Relations
Well, good morning, everyone. We really appreciate you all joining us today. Thank you for making the trip out here. For those of you who are in person. I’m Mark Wilterding, SVP of Global Finance and the Head of Investor Relations and along with the team had a role in putting today together and really excited for you to be here for the 2025 Edwards Life Sciences investor conference. We’ve got a great session planned for you today.
In addition to the executive leadership team that we have
